Is [ Non ST elevation acute coronary syndrome : early use of pravastatin or atorvastatin associated with divergent changes of parameters of hemostasis ]?
Early use of atorvastatin and pravastatin in patients with NSTEACS was associated with rapid divergent changes of some hemostatic parameters. Except lowering of von Willebrand factor changes in atorvastatin treated patients more resembled those in controls not receiving lipid lowering drugs. Von Willebrand factor was the only parameter which changes weakly but significantly correlated with changes of CH and LDL CH levels.
Intermittent G-CSF is effective in maintaining dose intensity in patients receiving ABVD.